IMRN

About Immuron Limited American Depositary Shares (IMRN) Stock

Immuron Limited American Depositary Shares (IMRN) closed the 2026-09-16 session at $1.19, down 4.03% versus the previous close (-0.05). The stock opened at $1.24 and traded between $1.19 and $1.28 during that session. Session trading volume was 149K shares. The volume-weighted average price (VWAP) is $1.22.

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company with a proprietary technology platform focused on polyclonal antibodies that can address unmet medical needs. The company's commercial products are: Travelan (an orally administered passive product indicated to reduce the risk of travelers' diarrhea and minor gastrointestinal disorders), and Protectyn, which is marketed as an immune supplement. Additionally, it has two clinical products in development, IMM124-E and IMM529, for the treatment of multiple high-value enteric disease indications. The firm has two reportable segments: Hyper-immune products, which derive maximum revenue, and Research and development. Geographically, the company generates maximum revenue from Australia, followed by the USA and Canada.

Immuron Limited American Depositary Shares has a market capitalization of $10.0 million. IMRN is listed on the XNAS exchange. The company employs approximately 7 people. The recorded listing date is 2007-12-13.

On this page you can find market IMRN stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.